APA (7th ed.) Citation

Joensuu, H., & Hohenberger, P. (2017). Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: An exploratory analysis of a randomized clinical triala. JAMA oncology, 3(5), . https://doi.org/10.1001/jamaoncol.2016.5751

Chicago Style (17th ed.) Citation

Joensuu, Heikki, and Peter Hohenberger. "Effect of KIT and PDGFRA Mutations on Survival in Patients with Gastrointestinal Stromal Tumors Treated with Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Triala." JAMA Oncology 3, no. 5 (2017). https://doi.org/10.1001/jamaoncol.2016.5751.

MLA (9th ed.) Citation

Joensuu, Heikki, and Peter Hohenberger. "Effect of KIT and PDGFRA Mutations on Survival in Patients with Gastrointestinal Stromal Tumors Treated with Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Triala." JAMA Oncology, vol. 3, no. 5, 2017, https://doi.org/10.1001/jamaoncol.2016.5751.